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ABSTRACT 
 
The concentration of interleukin-7 (IL-7) in human serum is elevated in various clinical conditions 
associated with lymphopenia, including HIV-1 infection. IL-7 is an essential factor for T cell 
differentiation and survival, and it was suggested that high serum IL-7 concentration may represent a 
homeostatic response to T cell depletion, which may promote T cell regeneration.  
In order to increase our understanding on the regulation of IL-7 production, we investigated specimens 
from HIV-1 infected patients during chronic infection and in long term non-progressors (LTNPs). Serum 
IL-7 levels correlated with T-cell depletion in HIV-1 infected individuals. In some patients, we observed 
that serum IL-7 decreased upon progression to AIDS, suggesting a role for IL-7 in T-cell maintenance in 
sporadic cases. Interestingly, IL-7 levels were significantly lower in stable LTNPs than in patients who 
lost the LTNP status in a 3-year follow-up (P<0.001), indicating that serum IL-7 concentration might be a 
valuable marker for maintenance of the LTNP status. 
The number of CD8+CD28- T cells increases significantly during aging and during HIV-1 infection. 
These cells have a reduced expression of the IL-7 receptor alpha (IL-7R), as compared to CD8+CD28+ 
T cells. As CD8+CD28- T cells have been associated with dendritic and T cell suppression, we analyzed 
whether an increase in CD8+CD28- T cell numbers during HIV-1 infection could lead to impaired T cell 
responses. Peripheral blood CD8+CD28- T cells of both HIV-infected and non-infected individuals 
promoted dendritic cell activation. The CD8+CD28- T cell accumulation during HIV-1 infection may 
thus contribute to inflammatory reactions and immune activation. 
Stromal cells and intestinal epithelial cells are known to produce IL-7. The mechanisms and cellular 
factors regulating IL-7 production are still unclear. We assessed whether IL-1 and IFN-, cytokines 
produced during inflammatory conditions, may impact on IL-7 production. We used human intestinal 
epithelial cells (DLD-1 cell line) and bone marrow stromal cells (HS27 cell line) to evaluate IL-7 
production at the mRNA and protein levels. To assess whether treatment of HS27 cells with IL-1 and/or 
IFN- leads to changes in the gene expression of cytokines, Toll-like receptors (TLRs) and chemokines, 
we analysed gene expression profiles using the whole-genome microarray Human Gene 1.0 ST. We found 
that IFN- enhanced the expression of IL-7 protein and mRNA (P<0.001) in both cell lines. IL-1 
treatment led to a significant down-regulation (P<0.001) of IL-7 mRNA expression in both cell lines. The 
gene profiles revealed dramatic changes in expression of cytokines and their receptors, of IFN regulatory 
factors (IRF-1 and 2) and of important chemo-attractants for T cells. The microarray results were verified 
by additional methods. Our results were discussed in the setting of inflammation and T-cell survival in the 
gut compartment during HIV-1 infection where stromal and epithelial cells may produce factors that 
contribute to impaired IL-7 homeostasis and homing of T cells.  
It was previously reported that IL-7 might stimulate T cell activation and CD95 mediated T cell 
apoptosis.  HIV-1 infection leads to B cell abnormalities including increased apoptosis via the CD95 
death receptor pathway and loss of memory B cells. Here we present a novel mechanism that can lead to 
increased B cell apoptosis in the presence of high IL-7 concentration. T cells cultured with IL-7 induced 
high CD95 expression on resting B cells together with an increased sensitivity to CD95 mediated 
apoptosis. As the mediator molecule responsible for B cell priming to CD95 mediated apoptosis we 
identified the cytokine IFN- that T cells secreted in response to IL-7. In the serum of HIV-1 infected 
individuals IL-7 and IFN-γ levels were in correlation and the level of both cytokines correlated with 
CD95 expression on circulating B lymphocytes in non-viremic individuals. These results indicate a potential 
link between IL-7 and the increased B cell apoptosis observed in HIV-1 infected individuals. 
In conclusion the results presented in this PhD thesis highlight mechanisms of regulation of IL-7 
production dependent on the number of circulating T cells and on the exposure of IL-7 producing cells to 
high levels of inflammatory cytokines. We also present data on the role of IL-7 in regulating CD95 
expression and CD95 mediated apoptosis on B cells through IFN- produced by T cells; the impact of this 
finding on the outcome of IL-7 therapy during HIV-1 infection will be verified by ongoing clinical 
studies. 
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